1. Home
  2. Analysis
  3. Pegintron
  4. Urticaria

Pegintron and Urticaria - a phase IV clinical study of FDA data

Summary:

Urticaria is reported as a side effect among people who take Pegintron (peginterferon alfa-2b), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Rebetol, and have Gastric ulcer.

The phase IV clinical study analyzes which people have Urticaria when taking Pegintron. It is created by eHealthMe based on reports of 10,295 people who have side effects when taking Pegintron from the FDA, and is updated regularly.

What is Pegintron?

Pegintron has active ingredients of peginterferon alfa-2b. It is often used in hepatitis c. eHealthMe is studying from 10,326 Pegintron users. Check the latest studies of Pegintron.

What is Urticaria?

Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,620 drugs and 2,952 conditions by eHealthMe. Check the latest studies of Urticaria.

On Jul, 17, 2026

10,295 people reported to have side effects when taking Pegintron.
Among them, 52 people (0.51%) have Urticaria.

Could Pegintron cause Urticaria?

Among these 52 people:

How long have people been on Pegintron when they have Urticaria? *

  • < 1 month: 30.43 %
  • 1 - 6 months: 56.52 %
  • 6 - 12 months: 8.7 %
  • 1 - 2 years: 4.35 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Urticaria when taking Pegintron? *

  • female: 48 %
  • male: 52 %

What is the age of people who have Urticaria when taking Pegintron? *

  • 0-1: 0.0 %
  • 2-9: 5.88 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 5.88 %
  • 40-49: 8.82 %
  • 50-59: 35.29 %
  • 60+: 44.12 %

What are other drugs people take besides Pegintron? *

  1. Rebetol: 22 people, 42.31%
  2. Victrelis: 12 people, 23.08%
  3. Ribavirin: 10 people, 19.23%
  4. Ribasphere: 5 people, 9.62%
  5. Incivek: 4 people, 7.69%
  6. Ribapak: 2 people, 3.85%
  7. Omega-3 Marine Triglycerides: 2 people, 3.85%
  8. Glucosamine: 2 people, 3.85%
  9. Vx-950: 2 people, 3.85%
  10. Copegus: 2 people, 3.85%

What are other side effects people have besides Urticaria? *

  1. Fatigue (feeling of tiredness): 16 people, 30.77%
  2. Rashes (redness): 15 people, 28.85%
  3. Itching: 15 people, 28.85%
  4. Fever: 11 people, 21.15%
  5. White Blood Cell Count Decreased: 11 people, 21.15%
  6. Hypersensitivity: 11 people, 21.15%
  7. Headache (pain in head): 10 people, 19.23%
  8. Influenza Like Illness: 9 people, 17.31%
  9. Pain: 9 people, 17.31%
  10. Anaemia (lack of blood): 8 people, 15.38%

What are the existing conditions these people have? *

  1. Hypokalemia (low potassium): 2 people, 3.85%
  2. Gastric Ulcer (stomach ulcer): 2 people, 3.85%
  3. Neurofibroma (non-cancerous tumours that grow on nerves throughout the body): 1 person, 1.92%
  4. Diabetes: 1 person, 1.92%
  5. Anaemia (lack of blood): 1 person, 1.92%

* Approximation only. Some reports may have incomplete information.

Do you take Pegintron and have Urticaria?

- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pegintron:

Urticaria treatments and more:

How severe was Urticaria and when was it recovered:

Expand to all the drugs that have ingredients of peginterferon alfa-2b:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pegintron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria:

Browse all the conditions that are associated with Urticaria:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on peginterferon alfa-2b (the active ingredients of Pegintron) and Pegintron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.